Results 241 to 250 of about 1,696,062 (260)

TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS

2014
COMBS ANDREW P, SPARKS RICHARD B, MADUSKUIE JR THOMAS P, RODGERS JAMES D   +3 more
openaire   +10 more sources

Tricyclic heterocycles as bet protein inhibitors

2016
COMBS ANDREW P, SPARKS RICHARD B
openaire   +4 more sources

Xanthine derivative inhibitors of BET proteins

2017
MORELLI XAVIER, COMBES SÉBASTIEN, GUILLEMOT JEAN-CLAUDE, BETZI STÉPHANE, COLLETTE YVES, ROCHE PHILIPPE, LUGARI ADRIEN, MILHAS SABINE, RAUX BRIGITT, VOITOVICH IULIIA   +9 more
openaire   +3 more sources

Killing pluripotent stem cells by BET protein inhibition

Science Bulletin, 2018
Shufeng, Ma, Ying, Lin, Zhili, Rong
openaire   +2 more sources

BET-PROTEIN-INHIBITING DIHYDROQUINOXALINONES

2014
SCHMEES NORBERT, HAENDLER BERNARD, STÖCKIGT DETLEF, GALLENKAMP DANIEL   +3 more
openaire   +1 more source

Co-targeting of BET proteins and HDACs as a novel approach to trigger apoptosis in rhabdomyosarcoma cells

Cancer Letters, 2018
Stefan Knapp, Marek Wanior, Simone Fulda
exaly  

BET-PROTEIN-INHIBITING DIHYDROPYRIDOPYRAZINONES

2014
SCHMEES NORBERT, BADER BENJAMIN, HAENDLER BERNARD, STÖCKIGT DETLEF, LEJEUNE PASCALE, FERNANDEZ-MONTALVAN AMAURY ERNESTO, STELLFELD TIMO, GALLENKAMP DANIEL   +7 more
openaire   +2 more sources

FUSED 1,4-DIAZEPINES AS BET PROTEIN DEGRADERS

2018
WANG SHAOMENG, HU YANG, QIN CHONG, XU FUMING, HU JIANTAO, XIANG WEIGUO, ZHOU BING   +6 more
openaire   +4 more sources

Precision Targeting of BET Proteins - Navigating Disease Pathways, Inhibitor Insights, and Shaping Therapeutic Frontiers: A Comprehensive Review

Current Drug Targets
Rakesh Amrutkar
exaly  

BET bromodomain proteins; smoothened (SMO)

Science-Business eXchange, 2014
openaire   +1 more source